<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr">
 
 <MediaTitle>immune checkpoint inhibitor (PD-1)</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>drawing</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>Color</Color>
   <Labeled>Yes</Labeled>
   
  <LabelName language="en">PD-L1 binds to PD-1 and inhibits T cell killing of tumor cell</LabelName><LabelName language="en">Tumor cell</LabelName><LabelName language="en">PD-L1</LabelName><LabelName language="en">PD-1</LabelName><LabelName language="en">Antigen</LabelName><LabelName language="en">T cell receptor</LabelName><LabelName language="en">T cell</LabelName><LabelName language="en">Blocking PD-L1 or PD-1 allows T cell killing of tumor cell</LabelName><LabelName language="en">Tumor cell death</LabelName><LabelName language="en">PD-L1</LabelName><LabelName language="en">Anti-PD-L1</LabelName><LabelName language="en">Anti-PD-1</LabelName><LabelName language="en">PD-1</LabelName><LabelName language="en">T cell</LabelName><ImageDimensions>
    <HeightPixels>2400</HeightPixels>
    <WidthPixels>3000</WidthPixels>
    
   </ImageDimensions></ImageData>
 </PhysicalMedia>
 <MediaSource>
  <OriginalSource>
   <Creator>Terese Winslow</Creator>
   
   
  <DateCreated>2016-06-08</DateCreated><SourceFilename>ImmuneCheckpointPD-L1.5.jpg</SourceFilename><Comment audience="Internal" date="2016-06-08" user="kuhlmanna">Revision: Changed label in the left panel to "PD-L1 binds to PD-1 and inhibits…cell” per OCC</Comment><Comment audience="Internal" date="2015-11-11" user="kuhlmanna">Added hyphens after "Anti-" for Anti-PD-L1 and Anti-PD-1</Comment><Comment audience="Internal" date="2015-09-21" user="yousufzaimg">Removed labels for Antigen and T-cell receptor from right image; removed hyphen from T cell and T cell receptor labels; smoothened appearance of tumor cell; and changed title of left image to "PD-L1/PD-1 binding inhibits T cell killing of tumor cell" and right image to "Blocking PD-L1 or PD-1 allows T cell killing of tumor cell"</Comment><Comment audience="Internal" date="2015-08-26" user="yousufzaimg">Made the T-Cell look a little “angrier” (a more ruffled appearance); made the tumor cell that is bound to the activated T cell look like it is dying and changed the label on it to say “Tumor cell death”; and changed titles on both panels to “explanations”: "PD-L1/PD-1 binding keeps T cell from killing tumor cell" and "Blocking PD-L1 or PD-1 allows T cell to kill tumor cell"</Comment><Comment>Rough draft</Comment></OriginalSource>
 </MediaSource>
 <MediaContent>
  <Categories>
   <Category>treatment</Category>
  </Categories>
  
  
  <ContentDescriptions>
   <ContentDescription audience="Patients" language="en">Immune checkpoint inhibitor; the panel on the left shows the binding of proteins PD-L1 (on the tumor cell) to PD-1 (on the T cell), which keeps T cells from killing tumor cells in the body. Also shown are a tumor cell antigen and T cell receptor. The panel on the right shows immune checkpoint inhibitors (anti-PD-L1 and anti-PD-1) blocking the binding of PD-L1 to PD-1, which allows the T cells to kill tumor cells.</ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Patients" language="en">Immune checkpoint inhibitor. Checkpoint proteins, such as PD-L1 on tumor cells and PD-1 on T cells, help keep immune responses in check. The binding of PD-L1 to PD-1 keeps T cells from killing tumor cells in the body (left panel). Blocking the binding of PD-L1 to PD-1 with an immune checkpoint inhibitor (anti-PD-L1 or anti-PD-1) allows the T cells to kill tumor cells (right panel).</MediaCaption>
  </Captions>
 </MediaContent>
 <ProposedUse>
  
  <Glossary cdr:ref="CDR0000772606">immune checkpoint inhibitor</Glossary>
 </ProposedUse>
 <ProcessingStatuses><ProcessingStatus>
        <ProcessingStatusValue>Processing Complete</ProcessingStatusValue>
        <ProcessingStatusDate>2016-06-09</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        <Comment>Image revision approved by OCC</Comment>
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Caption and content approved</ProcessingStatusValue>
        <ProcessingStatusDate>2016-06-08</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        <Comment>Caption revised per OCC</Comment>
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2015-11-16</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Caption and content approved</ProcessingStatusValue>
        <ProcessingStatusDate>2015-11-16</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Illustration review by group</ProcessingStatusValue>
        <ProcessingStatusDate>2015-11-16</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        <Comment audience="Internal" date="2015-11-11" user="kuhlmanna">Updated to ImmuneCheckpointPD-L1.4.jpg</Comment><Comment>Added ImmuneCheckpoint3.jpg</Comment>
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Draft illustration from artist</ProcessingStatusValue>
        <ProcessingStatusDate>2015-08-10</ProcessingStatusDate>
        <EnteredBy>yousufzaimg</EnteredBy>
        <Comment>Added ImmuneCheckpoint1.jpg</Comment>
       </ProcessingStatus>
  <ProcessingStatus>
   <ProcessingStatusValue>Sample illustrations sent to artist</ProcessingStatusValue>
   <ProcessingStatusDate>2015-08-04</ProcessingStatusDate>
   <EnteredBy>kuhlmanna</EnteredBy>
   
  </ProcessingStatus>
 </ProcessingStatuses>
<RelatedDocuments>
         <SupplementaryInfoLink cdr:ref="CDR0000774644">Sample Illustration: immunotherapy</SupplementaryInfoLink>
       </RelatedDocuments></Media>
